価格表

在庫・価格 : 2025年04月29日 23時55分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-SARS Nucleocapsid Protein, Rabbit-Poly
データシート
NB100-56683 NOVノバス バイオロジカルス
Novus biologicals, LLC
0.1 mg ¥96,000
(未発注)
追加

在庫・価格 : 2025年04月29日 23時55分 現在

Anti-SARS Nucleocapsid Protein, Rabbit-Poly

  • 商品コード:NB100-56683
  • メーカー:NOV
  • 包装:0.1mg
  • 価格: ¥96,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Shulla A et al. A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. J. Virol. 2011 Jan;85(2):873-82
Shulla A et al
2011/01/01
Applications: WB PubMed
2 Devaraj SG et al. Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus. J. Biol. Chem. 2007 Nov;282(44):32208-21
Devaraj SG et al
2007/01/01
Applications: PubMed
3 Wathelet MG et al. Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain. J. Virol. 2007 Nov;81(21):11620-33
Wathelet MG et al
2007/01/01
Applications: PubMed
4 Tseng CT et al. Apical entry and release of severe acute respiratory syndrome-associated coronavirus in polarized Calu-3 lung epithelial cells. J. Virol. 2005 Aug;79(15):9470-9
Tseng CT et al
2005/01/01
Applications: ICC/IF PubMed
5 Gupta V et al. SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens. Virology 2006 Mar;347(1):127-39
Gupta V et al
2006/01/01
Applications: WB PubMed
6 Cross RW et al. Use of convalescent serum reduces severity of COVID-19 in nonhuman primates. Cell Rep 2021 03;34(10):108837
Cross RW et al
2021/01/01
PubMed
7 Chapman AP et al. Rapid development of neutralizing and diagnostic SARS-COV-2 mouse monoclonal antibodies. Sci Rep 2021 05;11(1):9682
Chapman AP et al
2021/01/01
PubMed
8 Meng B et al. Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7. Cell Rep 2021 06;35(13):109292
Meng B et al
2021/01/01
PubMed
9 Poma AM et al. Activation of Type I and Type II Interferon signaling in SARS-CoV-2-positive thyroid tissue of patients dying from COVID-19. Thyroid 2021 Sep;
Poma AM et al
2021/01/01
PubMed
10 Schaller MA et al. Ex vivo SARS-CoV-2 infection of human lung reveals heterogeneous host defense and therapeutic responses. JCI Insight 2021 09;6(18)
Schaller MA et al
2021/01/01
Species: SARS-CoV-2, Applications: IHC PubMed
11 Tomchaney M et al. Paradoxical effects of cigarette smoke and COPD on SARS-CoV-2 infection and disease. BMC Pulm Med 2021 Aug;21(1):275
Tomchaney M et al
2021/01/01
Applications: ICC/IF PubMed
12 Poma AM et al. COVID-19 autopsy cases: detection of virus in endocrine tissues. J Endocrinol Invest 2021 Jun;
Poma AM et al
2021/01/01
PubMed
  • No.: 1
  • 文献情報:
    Shulla A et al. A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. J. Virol. 2011 Jan;85(2):873-82
    Shulla A et al
    2011/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Devaraj SG et al. Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus. J. Biol. Chem. 2007 Nov;282(44):32208-21
    Devaraj SG et al
    2007/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Wathelet MG et al. Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain. J. Virol. 2007 Nov;81(21):11620-33
    Wathelet MG et al
    2007/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Tseng CT et al. Apical entry and release of severe acute respiratory syndrome-associated coronavirus in polarized Calu-3 lung epithelial cells. J. Virol. 2005 Aug;79(15):9470-9
    Tseng CT et al
    2005/01/01
  • 備考:
    Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Gupta V et al. SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens. Virology 2006 Mar;347(1):127-39
    Gupta V et al
    2006/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Cross RW et al. Use of convalescent serum reduces severity of COVID-19 in nonhuman primates. Cell Rep 2021 03;34(10):108837
    Cross RW et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Chapman AP et al. Rapid development of neutralizing and diagnostic SARS-COV-2 mouse monoclonal antibodies. Sci Rep 2021 05;11(1):9682
    Chapman AP et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Meng B et al. Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7. Cell Rep 2021 06;35(13):109292
    Meng B et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Poma AM et al. Activation of Type I and Type II Interferon signaling in SARS-CoV-2-positive thyroid tissue of patients dying from COVID-19. Thyroid 2021 Sep;
    Poma AM et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Schaller MA et al. Ex vivo SARS-CoV-2 infection of human lung reveals heterogeneous host defense and therapeutic responses. JCI Insight 2021 09;6(18)
    Schaller MA et al
    2021/01/01
  • 備考:
    Species: SARS-CoV-2, Applications: IHC
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Tomchaney M et al. Paradoxical effects of cigarette smoke and COPD on SARS-CoV-2 infection and disease. BMC Pulm Med 2021 Aug;21(1):275
    Tomchaney M et al
    2021/01/01
  • 備考:
    Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Poma AM et al. COVID-19 autopsy cases: detection of virus in endocrine tissues. J Endocrinol Invest 2021 Jun;
    Poma AM et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed